|
2024
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and scien... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and gene ... |
|
|
G/S
|
Capital investment; Investment management; Equity capital investment; Providing venture capital, ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, ... |
|
|
G/S
|
Anti-inflammatory preparations; anti-viral agents; pharmaceutical anti-allergic preparations and ... |
|
2023
|
Invention
|
Anti-glp1r antagonist antibodies and methods of use thereof.
The present disclosure relates to a... |
|
|
Invention
|
Ultraviolet monitoring of chromatography performance by orthogonal partial least squares.
Disclo... |
|
|
Invention
|
Vl antigen binding proteins exhibiting distinct binding characteristics.
Methods for making, ide... |
|
|
Invention
|
Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis.
T... |
|
|
Invention
|
Therapeutic protein selection in simulated in vivo conditions.
A method of determining the effec... |
|
|
Invention
|
Cas-ready mouse embryonic stem cells and mice and uses thereof.
Methods and compositions are pro... |
|
|
Invention
|
Cell culture medium for eukaryotic cells.
Cell culture media are provided herein as are methods ... |
|
|
Invention
|
Needle shield grip devices and related methods.
A needle guard grip device may include a body ex... |
|
|
Invention
|
Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation.
Cas-p... |
|
|
Invention
|
Models of tauopathy.
BANF1, PPP2CA, and ANKLE2 were identified as genes that promote tau aggrega... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Syringes sold filled with pharmaceutical preparations for the treatment of ophthalmological disea... |
|
|
G/S
|
Syringes sold filled with pharmaceutical preparations for
the treatment of ophthalmological dise... |
|
|
Invention
|
Use of a vegf antagonist to treat angiogenic eye disorders.
The present invention provides metho... |
|
|
Invention
|
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof.
This disclosure rela... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Treatment of ophthalmic conditions with son of sevenless 2 (sos2) inhibitors.
The present disclo... |
|
|
Invention
|
Methods for reducing alloantibody levels in subjects in need of solid organ transplantation. B-ce... |
|
|
Invention
|
Vegf traps and mini-traps and methods for treating ocular disorders and cancer.
The present rela... |
|
|
Invention
|
Anti-ptcra antibody-drug conjugates and uses thereof.
The present disclosure provides antibody-d... |
|
|
Invention
|
Methods of treating cancer with bispecific egfr x cd28 antibodies alone or in combination with an... |
|
|
Invention
|
Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 si... |
|
|
Invention
|
Antibody resistant modified receptors to enhance cell-based therapies. Methods for improving engr... |
|
|
Invention
|
Genetically modified mice expressing components of human cellular immune system.
Disclosed herei... |
|
|
Invention
|
Genetically modified mice expressing components of human cellular immune system. Disclosed herein... |
|
|
Invention
|
Methods of treating obesity, diabetes, and liver dysfunction. The present disclosure relates to c... |
|
|
Invention
|
Treatment of endometriosis with r-spondin 3 (rspo3) inhibitors. The present disclosure relates ge... |
|
|
Invention
|
Treatment of endometriosis with r-spondin 3 (rspo3) inhibitors.
The present disclosure relates g... |
|
|
Invention
|
Method of treating an allergy with allergen-specific monoclonal antibodies.
The present inventio... |
|
|
Invention
|
Anti-gitr antibodies and uses thereof.
Provided herein are antibodies, and antigen-binding fragm... |
|
|
Invention
|
Methods of treating non-small cell lung cancer using mesenchymal epithelial transition factor (me... |
|
|
Invention
|
Genetically modified non-human animals and methods of use thereof.
Genetically modified non-huma... |
|
|
Invention
|
Anti-hemagglutinin antibodies and methods of use thereof.
Provided herein are monoclonal antibod... |
|
|
Invention
|
Interferon receptor agonists and uses thereof.
The present disclosure provides interferon recept... |
|
|
Invention
|
Methods for preventing or treating allergy by administering an il-4r antagonist.
The present inv... |
|
|
G/S
|
Pharmaceutical preparations for treatment of musculoskeletal, bone, and connective tissue disease... |
|
|
Invention
|
Genetically modified non-human animals expressing human epo.
Genetically modified non-human anim... |
|
|
Invention
|
Human antibodies to bet v 1 and methods of use thereof.
Provided herein are antibodies that bind... |
|
|
Invention
|
Steroids and protein-conjugates thereof.
Described herein are protein steroid conjugates that ar... |
|
|
Invention
|
Protein-antiviral compound conjugates.
Provided herein are compounds, compositions, and methods ... |
|
|
Invention
|
Macrophage stimulating 1 receptor (mst1r) variants and uses thereof.
Methods of treating patient... |
|
|
Invention
|
Vectors, genetically modified cells, and genetically modified non-human animals comprising the sa... |
|
|
Invention
|
Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist.
The present in... |
|
|
Invention
|
Auto-injector and related methods of use.
An auto-injector may include a container capable of co... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
Invention
|
Treatment of decreased bone mineral density with zinc and ring finger 3 (znrf3) inhibitors.
The ... |
|
|
Invention
|
Humanized non-human animals with restricted immunoglobulin heavy chain loci.
Mice, embryos, cell... |
|
|
Invention
|
Compositions and methods for increasing muscle mass and muscle strength by specifically antagoniz... |
|
|
Invention
|
Aplnr modulators and uses thereof.
The present invention provides apelin receptor (APLNR) modula... |
|
2022
|
Invention
|
Antibodies to human gdf8.
The present invention provides isolated human or humanized antibodies ... |
|
|
Invention
|
Methods for analysis of viral capsid protein composition.
Methods of determining the stoichiomet... |
|
2021
|
Invention
|
Mice expressing humanized fc alpha receptors.
Provided herein are methods and compositions relat... |
